PHLPP2 as a novel metastatic and prognostic biomarker in non‐small cell lung cancer patients

BACKGROUND: PH domain and leucine‐rich repeat protein phosphatase 2 (PHLPP2) has been reported to be a potent tumor suppressor in many human cancers. However, PHLPP2 has not been fully researched as a putative clinical prognostic biomarker of lung cancer. METHODS: The Cancer Genome Atlas (TCGA) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongmei, Gu, Ruixue, Tian, Fanglin, Liu, Yuechao, Fan, Weina, Xue, Guiqin, Cai, Li, Xing, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825916/
https://www.ncbi.nlm.nih.gov/pubmed/31571378
http://dx.doi.org/10.1111/1759-7714.13196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825916/
https://www.ncbi.nlm.nih.gov/pubmed/31571378
http://dx.doi.org/10.1111/1759-7714.13196

Ejemplares similares